When adjusted for acquisitions and exchange rate effects, this amounts to organic growth of 10.5%.
Employees of the Otto Bock HealthCare Group
During the course of the 2012 fiscal year, the number of full-time employees increased by 406 to 5,196 of whom 104 persons are apprentices.
Sales by business area
We develop, manufacture and sell orthopaedic technology products (Orthobionic) and rehabilitation products (Bionicmobility) worldwide. In addition to products for prosthetic fittings, the Orthobionic product range also includes orthoses and epitheses as well as devices for passive exercise therapy. We are global market leader in prosthetics. Products in the Bionicmobility division include high-quality lightweight and active wheelchairs, power wheelchairs, child rehabilitation devices and seating shell elements, neuroimplants and products for functional electrostimulation. In 2011, 83.0% of our net sales were attributed to the Orthobionic division. We have achieved good nominal growth rates in both business divisions.
When adjusted for exchange rate effects and acquisitions, that rate was 15.6% in the Bionicmobility business area and 9.6% in the Orthobionic business area.